most frequently during the first trimester when the highest amount of gonadotropin is produced (3) . Prolactin hormone is the first of the hormones shown as a target in etiology. Additionally, other hormones such as progesterone, estrogen, thyroxine, growth hormone, cortisol, insulin and human placental lactogen are also considered to have an effect (4). Lafreniare et al. (5) demonstrated that prolactin levels were high in this type of patient in their study. In our study, the prolactin level was 110 ng/mL (normal: 1.2-29.9 ng/mL). Furthermore, a patient with rheumatoid arthritis was reported to have gigantomastia due to D-penicillamine use in the etiology (6) . Drugs such as cyclosporine and bucillamine are also blamed in the etiology. Moreover, Touraine et al. (7) stated that immunologic and hormonal reasons were effective in their study. It was proven that breast tissue was a potential target tissue in autoimmune diseases such as myasthenia gravis, chronic arthritis, and Hashimoto's thyroiditis, and that an autoimmune mechanism was effective in the etiology of the disease and immunohistochemical analysis of breast tissues (7). In the differential diagnosis, a phyllodes tumor, fibroadenom, Non-Hodgkin's lymphoma and lymphoblastic lymphoma can be excluded through biopsy. Having analyzed mastectomy samples of patients with gestational gigantomastia histologically, Swelstad et al. discovered significant lobular hypertrophy, ductal proliferation and periductal fibrosis (8) . Furthermore, gestational gigantomastia can be accompanied by histologic alterations such as extensive lobular hyperplasia, dilated tracts, and pseudoangiomatous hyperplasia. Although the effects of the disease can be seen more frequently in multiparous women, there is no relationship between the disease and the number of pregnancies (2, 9, 10). Patients with this disease might experience social and psychologic problems, as well as difficulty with movement and breathing.
Conservative treatment with bromocriptine, a dopaminergic receptor agonist, is the preferred option for the treatment. Even though it halts breast growth, it has no apparent effect on reducing breast size (11) . Furthermore, tamoxifen, hydrocortisone, diuretics, and medroxyprogesterone are included in the conservative treatment. Breast-conserving surgery could cause relapse; therefore, mastectomy is recommended for patients with this disease (8) . In a study by Swelstad (8) , 100% of the patients (4 patients) who underwent breast reduction surgery for gestational gigantomastia relapsed when they were pregnant again after the operation. We also preferred mastectomy in consideration of possible relapses after breast reduction surgery.
Consequently, gestational gigantomastia may begin in any pregnancy and recur during following pregnancies. Hyperprolactinemia is a common condition in patients with gestational gigantomastia; however, it does not require the termination of the pregnancy (3). The best possible treatment option is total mastectomy. We believe potential problems that may arise should be considered and measures should be taken in order to cope with a possible venous lake and severe anemia due to hemorrhage during surgery.
Informed Consent: Written informed consent was obtained from patient. 
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